Syros Pharmaceuticals Stock (NASDAQ: SYRS) stock price, news, charts, stock research, profile.
You can purchase shares of Syros Pharmaceuticals (NASDAQ:SYRS) through any online brokerage.
Other companies in Syros Pharmaceuticals’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Alzamend Neuro (NASDAQ:ALZN), Galecto (NASDAQ:GLTO) and Quoin Pharmaceuticals (NASDAQ:QNRX).
Syros Pharmaceuticals has a consensus price target of $7.25.
The stock price for Syros Pharmaceuticals (NASDAQ: SYRS) is $0.2103 last updated January 17, 2025 at 6:39 PM EST.
There are no upcoming dividends for Syros Pharmaceuticals.
Syros Pharmaceuticals’s Q4 earnings are confirmed for Wednesday, March 26, 2025.
There is no upcoming split for Syros Pharmaceuticals.
Syros Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.